SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma

被引:0
作者
Zengbin Wang
Banglun Pan
Lili Su
Huahui Yu
Xiaoxuan Wu
Yuxin Yao
Xiaoxia Zhang
Jiacheng Qiu
Nanhong Tang
机构
[1] Fujian Medical University,Department of Immunology, School of Basic Medical Sciences
[2] Fujian Medical University Union Hospital,Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery
[3] Cancer Center of Fujian Medical University,undefined
[4] Fujian Medical University Union Hospital,undefined
[5] Key Laboratory of Gastrointestinal Cancer (Fujian Medical University),undefined
[6] Ministry of Education,undefined
来源
Cellular Oncology | 2024年 / 47卷
关键词
SUMOylation inhibitors; Intestinal microbiota; Immune microenvironment; Hepatocellular carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:513 / 532
页数:19
相关论文
共 481 条
[1]  
El-Khoueiry AB(2017)undefined Lancet 389 2492-2502
[2]  
Sangro B(2019)undefined Gut 68 1653-1666
[3]  
Yau T(2019)undefined Mol. Cancer 18 130-309
[4]  
Crocenzi TS(2020)undefined Cancer Lett. 469 301-418
[5]  
Kudo M(2018)undefined Mol. Cell 71 409-357
[6]  
Hsu C(2018)undefined Front. Cardiovasc. Med. 8 ARTN 701583-242
[7]  
Kim TY(2006)undefined Mol. Cell 21 349-149
[8]  
Choo SP(2015)undefined Trends Biochem. Sci. 40 233-6803
[9]  
Trojan J(2016)undefined Nat. Immunol. 17 140-595
[10]  
Welling THR(2018)undefined Proc. Natl. Acad. Sci. U. S. A. 115 6798-1298